Form 4: Procept BioRobotics EVP, CFO Kevin Waters Reports Stock Option Exercises
SEC Form 4 Filing
Kevin Waters, EVP and CFO of Procept BioRobotics, reports exercising stock options and subsequent changes in beneficial ownership.
Summary
- On March 15, 2024, Kevin Waters, the EVP and CFO of Procept BioRobotics Corp, exercised stock options.
- He exercised options to acquire 36,010 shares at $4.52 and 17,747 shares at $4.56.
- Following these transactions, Waters directly owns 103,173 shares of common stock.
- He also holds 15,917 stock options with an exercise price of $4.52 and 53,243 stock options with an exercise price of $4.56.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option exercises. The executive exercising options could be seen as a mildly positive signal.
Positives
- The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The stock option exercise could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/23/2018 | Date the stock option for 36,010 shares was granted, vesting over four years. |
| 12/12/2019 | Date the stock option for 17,747 shares was granted, vesting over four years. |
| 03/15/2024 | Date of stock option exercises. |
| 03/18/2024 | Date of signature on the Form 4 filing. |
| 10/22/2028 | Expiration date of the stock option for 36,010 shares. |
| 12/11/2029 | Expiration date of the stock option for 17,747 shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.